【Recursion CEO谈人工智能对药物研发的帮助】英伟达向生物技术公司Recursion投资5000万美元。两家公司表示,将加快该生物技术公司用于药物发现的人工智能模型的开发。Recursion首席执行官Chris Gibson表示,与英伟达的合作代表了两家一流公司的合作,将帮助解决世界上最困难的挑战之一——药物发现。”Recursion使用人工智能驱动的模型来识别和设计新的疗法,并将这些模型提供给包括罗氏、拜耳等在内的其他制药商。 $NVIDIA Corp(NVDA)$ $Recursion Pharmaceuticals, Inc.(RXRX)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet